Table 9. Recommendations of intensive adjuvant therapy for triple negative breast cancer.

Stratification	Level I recommendations	Level II recommendations
In the presence of any of the following conditions: (I) positive lymph nodes; (II) tumor sized >2 cm
Without BRCA mutations	−	Chemotherapy followed by sequential capecitabine for 1 year (2A)
With BRCA mutations	−	Chemotherapy followed by sequential olaparib for 1 year (1B)
Negative lymph nodes and tumor sized 1–2 cm	−	Chemotherapy followed by sequential capecitabine for 1 year (2B)